|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/22 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61K 49/16 | (2006.01) | ||
| A61K 51/10 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C12P 21/08 | (2006.01) |
| (11) | Number of the document | 4339615 |
| (13) | Kind of document | T |
| (96) | European patent application number | 24150762.3 |
| Date of filing the European patent application | 2017-09-09 | |
| (97) | Date of publication of the European application | 2024-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-05 |
| (46) | Date of publication of the claims translation | 2025-12-10 |
| (30) | Number | Date | Country code |
| 201662395832 P | 2016-09-16 | US | |
| 201762519590 P | 2017-06-14 | US |
| (72) |
JIANG, Weidong , CN
LIN, Pei-Hua , CN
TSENG, Chi-Ling , CN
|
| (73) |
Shanghai Henlius Biotech, Inc. ,
Room 303, 304, Block 7
No. 1999 Zhangheng Road
Pilot Free Trade Zone, Shanghai,
CN
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai prieš PD-1, skirti naudoti vėžio gydymui |
| ANTI-PD-1 ANTIBODIES FOR USE IN THE TREATMENT OF CANCER |